The Daily Buyout
~$375MreportedTake-privateHealthcare & Life SciencesCompleted

Altaris completes take-private of Simulations Plus

Simulations Plus, the Nasdaq-listed developer of model-informed and AI-accelerated drug development software, announced the completion of its acquisition by affiliates of healthcare-focused investment firm Altaris. The transaction was originally announced on June 16, 2026, and shares of the company were converted at the effective time of the merger.

Why it matters: Another listed life-sciences software name leaves the public markets as healthcare-specialist buyout firms keep hunting for niche, high-margin pharma tools.

Read the full coverage, free

We only link to sources you can read without a subscription. How we check.

Following healthcare M&A?

The next big healthcare deal will be in our email the morning after it's announced, with the rest of the day's biggest deals. Free, with no paywalled links.

Free · Unsubscribe anytime

See what you get →